An Open-Label, Safety and Efficacy Study of Cebranopadol in Participants With Acute Pain With Surgical or Non-Surgical Origin

cebranopadol (TRN-228) - Tris Pharma, Adneuris Therapeutics

An Open-Label, Safety and Efficacy Study of Cebranopadol in Participants With Acute Pain With Surgical or Non-Surgical Origin (clinicaltrials.gov) - Oct 1, 2026 - P3 | N=160 | Recruiting | Sponsor: Adneuris Therapeutics, Inc.
New P3 trial • Pain

http://clinicaltrials.gov/ct2/show/NCT07845071

Oct 1, 2026